- Home
- PRAX vs AHG Comparison
PRAX vs AHG Comparison
Compare PRAX & AHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- AHG
- Stock Information
- Founded
- PRAX 2015
- AHG 2013
- Country
- PRAX United States
- AHG China
- Employees
- PRAX N/A
- AHG N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- AHG Business Services
- Sector
- PRAX Health Care
- AHG Consumer Discretionary
- Exchange
- PRAX Nasdaq
- AHG Nasdaq
- Market Cap
- PRAX 599.7M
- AHG 650.1M
- IPO Year
- PRAX 2020
- AHG N/A
- Fundamental
- Price
- PRAX $38.55
- AHG $1.47
- Analyst Decision
- PRAX Strong Buy
- AHG
- Analyst Count
- PRAX 10
- AHG 0
- Target Price
- PRAX $116.50
- AHG N/A
- AVG Volume (30 Days)
- PRAX 320.6K
- AHG 20.8K
- Earning Date
- PRAX 05-02-2025
- AHG 06-06-2025
- Dividend Yield
- PRAX N/A
- AHG N/A
- EPS Growth
- PRAX N/A
- AHG N/A
- EPS
- PRAX N/A
- AHG N/A
- Revenue
- PRAX $8,122,000.00
- AHG $8,454,946.00
- Revenue This Year
- PRAX N/A
- AHG N/A
- Revenue Next Year
- PRAX N/A
- AHG N/A
- P/E Ratio
- PRAX N/A
- AHG N/A
- Revenue Growth
- PRAX 270.02
- AHG 281.19
- 52 Week Low
- PRAX $26.70
- AHG $0.62
- 52 Week High
- PRAX $91.83
- AHG $2.35
- Technical
- Relative Strength Index (RSI)
- PRAX 53.72
- AHG 48.09
- Support Level
- PRAX $35.21
- AHG $1.54
- Resistance Level
- PRAX $38.90
- AHG $1.98
- Average True Range (ATR)
- PRAX 2.09
- AHG 0.22
- MACD
- PRAX 0.07
- AHG -0.01
- Stochastic Oscillator
- PRAX 69.58
- AHG 13.56
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About AHG Akso Health Group ADS
Akso Health Group formerly Xiaobai Maimai Inc is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.